5dk3
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Crystal Structure of Pembrolizumab, a full length IgG4 antibody== | ==Crystal Structure of Pembrolizumab, a full length IgG4 antibody== | ||
- | <StructureSection load='5dk3' size='340' side='right' caption='[[5dk3]], [[Resolution|resolution]] 2.28Å' scene=''> | + | <StructureSection load='5dk3' size='340' side='right'caption='[[5dk3]], [[Resolution|resolution]] 2.28Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[5dk3]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5DK3 OCA]. For a <b>guided tour on the structure components</b> use [http:// | + | <table><tr><td colspan='2'>[[5dk3]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5DK3 OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5DK3 FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=SUC:SUCROSE'>SUC</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=SUC:SUCROSE'>SUC</scene></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http:// | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5dk3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5dk3 OCA], [http://pdbe.org/5dk3 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5dk3 RCSB], [http://www.ebi.ac.uk/pdbsum/5dk3 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5dk3 ProSAT]</span></td></tr> |
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
Line 16: | Line 16: | ||
</div> | </div> | ||
<div class="pdbe-citations 5dk3" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5dk3" style="background-color:#fffaf0;"></div> | ||
+ | |||
+ | ==See Also== | ||
+ | *[[Keytruda|Keytruda]] | ||
+ | *[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]] | ||
+ | *[[Pembrolizumab/Keytruda|Pembrolizumab/Keytruda]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
+ | [[Category: Human]] | ||
+ | [[Category: Large Structures]] | ||
[[Category: Prosise, W]] | [[Category: Prosise, W]] | ||
[[Category: Reichert, P]] | [[Category: Reichert, P]] |
Revision as of 08:07, 8 April 2020
Crystal Structure of Pembrolizumab, a full length IgG4 antibody
|
Categories: Human | Large Structures | Prosise, W | Reichert, P | Scapin, G | Antibody | Cancer | Igg4 | Immune system | Melanoma | Subclass